{
  "paper": "909e785543bb6169293392cec359db6b.txt",
  "words": 17742,
  "extractions": {
    "title": {
      "value": "RECOVER identifies synergistic drug combinations in vitro through sequential model optimization",
      "justification": "The title clearly indicates the focus of the research on identifying synergistic drug combinations using the RECOVER model.",
      "quote": "RECOVER identifies synergistic drug combinations in vitro through sequential model optimization"
    },
    "description": "The paper discusses the use of a deep learning model called RECOVER to identify and evaluate synergistic drug combinations using only a small fraction of the possible search space in vitro. It utilizes a sequential model optimization approach to guide wet-lab experiments efficiently.",
    "type": {
      "value": "empirical",
      "justification": "The paper describes empirical experiments carried out using the RECOVER model to identify synergistic drug combinations, along with in vitro testing such as cell viability assays.",
      "quote": "For large libraries of small molecules, exhaustive combinatorial screens become infeasible. Through five rounds of experimentation, Bertin et al. utilize a deep learning model to guide cell viability assays and select drug combinations."
    },
    "primary_research_field": {
      "name": {
        "value": "Biomedical Research",
        "justification": "The paper is focused on identifying drug combinations which is a key area in biomedical research, especially related to drug discovery and development.",
        "quote": "The goal of this work is to discover synergistic drug combinations while only requiring minimal wet-lab experimentation."
      },
      "aliases": [
        "Drug Discovery",
        "Biomedicine"
      ]
    },
    "sub_research_fields": [
      {
        "name": {
          "value": "Cancer Research",
          "justification": "The research involves testing drug combinations on a breast cancer model cell line, MCF7.",
          "quote": "Finally, we test RECOVER prospectively in an in vitro experimental setting, whereby we discover novel synergistic combinations active against a breast cancer model cell line, MCF7."
        },
        "aliases": [
          "Oncology"
        ]
      },
      {
        "name": {
          "value": "Machine Learning",
          "justification": "The paper applies machine learning techniques for drug synergy prediction via the RECOVER model.",
          "quote": "Deep learning models have achieved state-of-the-art results in silico for the prediction of synergy scores."
        },
        "aliases": [
          "AI in Biomedicine"
        ]
      }
    ],
    "models": [
      {
        "name": {
          "value": "RECOVER",
          "justification": "The RECOVER model is explicitly mentioned as the primary deep learning model used for synergy prediction and guiding drug combination experiments.",
          "quote": "RECOVER is an open-source SMO platform for the optimal suggestion of drug combinations."
        },
        "aliases": [],
        "is_contributed": {
          "value": true,
          "justification": "RECOVER is a key contribution of the paper as it is the main model used.",
          "quote": "We present a SMO platform that can guide wet-lab experiments: RECOVER, a deep learning regression model that predicts synergy using molecular fingerprints as inputs."
        },
        "is_executed": {
          "value": true,
          "justification": "The RECOVER model was actively used and tested through the experiments described in the paper.",
          "quote": "We perform multiple rounds of RECOVER-informed wet-lab experiments and observe sequential improvements in performance."
        },
        "is_compared": {
          "value": true,
          "justification": "RECOVER is compared against other methods like DeepSynergy to evaluate performance.",
          "quote": "We first observe that DeepSynergy performs worse than random, while RECOVER (without SMO) performs slightly above the level of randomness."
        },
        "referenced_paper_title": {
          "value": "",
          "justification": "The paper does not reference another paper for the RECOVER model but contributes it instead.",
          "quote": ""
        }
      }
    ],
    "datasets": [
      {
        "name": {
          "value": "NCI-ALMANAC",
          "justification": "The NCI-ALMANAC is explicitly mentioned as a dataset used for pretraining and evaluation.",
          "quote": "We refrain from combining multiple datasets because of the severe batch effects between studies; in Figure S1F, we show a scatterplot that demonstrates inconsistency between the O’Neil et al. series of drug combination experiments against their NCI-ALMANAC counterpart."
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "The national cancer institute almanac: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity",
          "justification": "The dataset is referenced as a screening resource for anticancer drug pairs with enhanced therapeutic activity.",
          "quote": "The national cancer institute almanac: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity."
        }
      },
      {
        "name": {
          "value": "DrugComb",
          "justification": "DrugComb is used for providing additional drug combination data and comparison with the study’s findings.",
          "quote": "The prediction set for experiment selection was built by taking 54 out of the 95 Almanac drugs for which a mechanism of action (MoA) was annotated in ChEMBL 25."
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "DrugComb: an integrative cancer drug combination data portal",
          "justification": "The DrugComb database is described as an integrative portal for drug combinations, which aligns with its usage in this study.",
          "quote": "DrugComb: an integrative cancer drug combination data portal."
        }
      },
      {
        "name": {
          "value": "O'Neil Study",
          "justification": "The O'Neil study is used for pretraining and comparing models to assess generalization capabilities.",
          "quote": "We confirm the significant batch effects between the NCI-ALMANAC and the O’Neil 2016 studies render using the same model parameters for both studies impossible."
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "An unbiased oncology compound screen to identify novel combination strategies",
          "justification": "The paper explicitly references the O'Neil study in the context of unbiased oncology screens to identify combination strategies.",
          "quote": "An unbiased oncology compound screen to identify novel combination strategies."
        }
      }
    ],
    "libraries": [
      {
        "name": {
          "value": "Scikit-learn",
          "justification": "Scikit-learn is mentioned as part of the data processing pipeline for model training.",
          "quote": "Clustering was performed with the k-medoids algorithm as implemented in scikit-learn 0.24.2 (n_clusters = 54, metric = Tanimoto similarity, init = k-medoids++)."
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "Scikit-learn: Machine learning in Python",
          "justification": "The Scikit-learn library is referenced for its machine learning capabilities, aligning with its usage in the research.",
          "quote": "Scikit-learn: Machine learning in Python."
        }
      },
      {
        "name": {
          "value": "RDKit",
          "justification": "RDKit is used for chemical informatics, particularly for representing drug structures.",
          "quote": "Replacements for each of the three drugs were selected by taking the nearest analogue (evaluated by Tanimoto similarity) in the same cluster. 54 Almanac and 54 non-Almanac compounds thus selected were used to build a set of 2916 binary combinations made up by one Almanac and one non-Almanac compound."
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "RDKit: Open-Source Cheminformatics",
          "justification": "The RDKit library is referenced for its capabilities in cheminformatics, which is leveraged in the study.",
          "quote": "RDKit: Open-Source Cheminformatics."
        }
      }
    ]
  },
  "usage": {
    "completion_tokens": 1433,
    "prompt_tokens": 30511,
    "total_tokens": 31944,
    "completion_tokens_details": null,
    "prompt_tokens_details": null
  }
}